The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Honoraria - Lilly; Pfizer; SynCoreBio
Consulting or Advisory Role - Bristol-Myers Squibb

Silmitasertib (CX-4945) in combination with gemcitabine and cisplatin as first-line treatment for patients with locally advanced or metastatic cholangiocarcinoma: A phase Ib/II study.
Mitesh J. Borad
Stock and Other Ownership Interests - AVEO; Gilead Sciences; Intercept Pharmaceuticals; Spectrum Pharmaceuticals
Consulting or Advisory Role - Agios (Inst); ArQule (Inst); Celgene (Inst); De Novo Pharmaceuticals; Exelixis; Fujifilm (Inst); G1 Therapeutics; Genentech; Halozyme (Inst); Immunovative Therapies; Imvax; Inspyr Therapeutics; Insys Therapeutics (Inst); Klus Pharma; Lynx Group; Merck; Novartis (Inst); Pieris Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Western Oncolytics
Research Funding - Adaptimmune (Inst); Agios (Inst); ARIAD (Inst); Basilea (Inst); BiolineRx (Inst); Boston Biomedical (Inst); Celgene (Inst); Dicerna (Inst); Eisai (Inst); EMD Serono (Inst); Halozyme (Inst); ImClone Systems (Inst); Incyte (Inst); Incyte (Inst); Isis Pharmaceuticals (Inst); MedImmune (Inst); Merck Serono (Inst); miRNA Therapeutics (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); RedHill Biopharma (Inst); Senhwa Biosciences (Inst); Sillajen (Inst); Sun Biopharma (Inst); Taiho Pharmaceutical (Inst); Threshold Pharmaceuticals (Inst); Toray Industries (Inst)
Travel, Accommodations, Expenses - ArQule; AstraZeneca; Celgene
Li-Yuan Bai
No Relationships to Disclose
Ming-Huang Chen
No Relationships to Disclose
Joleen M. Hubbard
Consulting or Advisory Role - Bayer (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); eFFECTOR Therapeutics (Inst); Hutchison MediPharma (Inst); Merck (Inst); Senhwa Biosciences (Inst); Taiho Pharmaceutical (Inst); Treos Bio (Inst)
Kabir Mody
Stock and Other Ownership Interests - CytoDyn; Oncotherapeutics
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Genentech/Roche; Ipsen; Merrimack; Vicus Therapeutics
Research Funding - Agios; ARIAD; ArQule; AstraZeneca (Inst); Basilea (Inst); FibroGen; Gritstone Bio (Inst); Incyte (Inst); MedImmune; Merck (Inst); Senhwa Biosciences; Taiho Pharmaceutical; TRACON Pharma; Turnstone Bio (Inst); Vyriad (Inst)
Sun Young Rha
Consulting or Advisory Role - Abbvie; Amgen; Daiichi Sankyo; Eisai; Ipsen; MSD Oncology; Novartis
Speakers' Bureau - Ipsen; Lilly
Research Funding - ASLAN Pharmaceuticals; Bayer; Bristol-Myers Squibb; Cellid; Eisai; Immunome; medpacto; MSD Oncology; Roche/Genentech; Sillajen
Donald A. Richards
Consulting or Advisory Role - Ipsen; Seattle Genetics/Astellas; Taiho Pharmaceutical
S. Lindsey Davis
Honoraria - Bristol-Myers Squibb; Incyte; OncLive
Speakers' Bureau - Allergan (I); Teva (I)
Research Funding - AstraZeneca (Inst); Boston Scientific (I); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Merck (Inst); OncoMed (Inst); Roche (Inst); Senhwa Biosciences (Inst)
John Soong
Employment - Senhwa Biosciences
Leadership - Senhwa Biosciences; Senhwa Biosciences
Stock and Other Ownership Interests - Senhwa Biosciences
Patents, Royalties, Other Intellectual Property - I hold multiple patents relating to the small molecules CX-4945 and CX-5461
Travel, Accommodations, Expenses - Senhwa Biosciences
Chi-En C-E Huang
Employment - Senhwa Biosciences
Stock and Other Ownership Interests - Senhwa Biosciences
Emmett Tse
Employment - Senhwa Biosciences
Stock and Other Ownership Interests - Pfizer
Daniel H. Ahn
Consulting or Advisory Role - Celltrion (I); Eisai; Exelixis; Genentech/Roche
Research Funding - AstraZeneca; Bayer
Heung-Moon Chang
Research Funding - Astellas Pharma (Inst); Halozyme (Inst); Pharmacyclics (Inst); Senhwa Biosciences (Inst); Taiho Pharmaceutical (Inst)
Chia-Jui Yen
No Relationships to Disclose
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; AstraZeneca; Bayer; Celgene; Genentech/Roche; Halozyme; Merck Serono; Novartis; Taiho Pharmaceutical; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; Lilly; Novartis
Joon Oh Park
Consulting or Advisory Role - AstraZeneca; Celgene; GI Innovation; Merck Serono; SERVIER
Speakers' Bureau - Celgene
Research Funding - Celgene; medpacto
Chiun Hsu
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb-Ono Pharmaceutical; Eisai; Ipsen; Lilly; Merck Serono; MSD; Novartis; PharmaEngine; Roche; TTY Biopharm
Research Funding - Bristol-Myers Squibb-Ono Pharmaceutical; Ipsen; Roche
Travel, Accommodations, Expenses - Ipsen; PharmaEngine; Roche; TTY Biopharm
Carlos Roberto Becerra
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Agenus; Bayer; HERON; Ipsen; SOBI; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Taiho Pharmaceutical
Jen-Shi Chen
Research Funding - Astellas Pharma; AstraZeneca; Debiopharm Group; Janssen; Lilly; Merck KGaA; MSD Oncology; Ono Pharmaceutical; Roche; Senhwa Biosciences; SynCoreBio; TTY Biopharm
Yen-Yang Chen
No Relationships to Disclose